Inventor
BONFANTI JEAN-FRANÇOIS
FR30 patents
⚠️ This page may combine multiple inventors who share the name “BONFANTI JEAN-FRANÇOIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICALS INC
20 patentsUS10029984B2Jul 24, 2018
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC21 citations94
US9944598B2Apr 17, 2018
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC21 citations94
US10206902B2Feb 19, 2019
Mono- or di-substituted indoles as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC14 citations85
US11827602B2Nov 28, 2023
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC2 citations73
US10919854B2Feb 16, 2021
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC3 citations73
US10696632B2Jun 30, 2020
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC3 citations73
US11180450B2Nov 23, 2021
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC2 citations72
US10689340B2Jun 23, 2020
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC4 citations72
US12172959B2Dec 24, 2024
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations62
US11083707B2Aug 10, 2021
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations62
US10913716B2Feb 9, 2021
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations62
US11795149B2Oct 24, 2023
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations61
US11407715B2Aug 9, 2022
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations61
US11702387B2Jul 18, 2023
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations59
US11053196B2Jul 6, 2021
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations59
US10786484B2Sep 29, 2020
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations52
US10765662B2Sep 8, 2020
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations52
US11179368B2Nov 23, 2021
Substituted indoline derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations51
US10646469B2May 12, 2020
Substituted indole derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations51
US10730884B2Aug 4, 2020
Substituted indole compound derivatives as dengue viral replication inhibitors
JANSSEN PHARMACEUTICALS INC0 citations38
JANSSEN SCIENCES IRELAND UNLIMITED CO
4 patentsUS11702426B2Jul 18, 2023
Macrocyclic deaza-purinones for the treatment of viral infections
JANSSEN SCIENCES IRELAND UNLIMITED CO0 citations61
US11104678B2Aug 31, 2021
Purine derivatives for the treatment of viral infections
JANSSEN SCIENCES IRELAND UNLIMITED CO0 citations61
US10829494B2Nov 10, 2020
Macrocyclic deaza-purinones for the treatment of viral infections
JANSSEN SCIENCES IRELAND UNLIMITED CO0 citations51
US10822349B2Nov 3, 2020
Macrocyclic purines for the treatment of viral infections
JANSSEN SCIENCES IRELAND UNLIMITED CO0 citations50